US Bancorp DE Lowers Position in RELX PLC (NYSE:RELX)

Key Points

• US Bancorp DE has reduced its stake in RELX PLC by 7.1%, selling 18,641 shares to end with 242,369 shares valued at $12.2 million.
• Several other institutional investors also increased their holdings, with Larson Financial Group LLC raising its stake by 612.5% during the same quarter.
• RELX announced a semi-annual dividend of $0.2634 per share, payable on September 16th, representing a yield of 170.0% with a payout ratio of 65.05%.

US Bancorp DE trimmed its stake in shares of RELX PLC (NYSE:RELX - Free Report) by 7.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 242,369 shares of the technology company's stock after selling 18,641 shares during the quarter. US Bancorp DE's holdings in RELX were worth $12,218,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the business. Ameriprise Financial Inc. lifted its holdings in RELX by 368.7% in the 4th quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company's stock worth $127,437,000 after buying an additional 2,208,119 shares during the period. Northern Trust Corp lifted its holdings in RELX by 51.6% in the 4th quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company's stock worth $99,542,000 after buying an additional 745,532 shares during the period. GAMMA Investing LLC lifted its holdings in RELX by 6,125.5% in the 1st quarter. GAMMA Investing LLC now owns 679,073 shares of the technology company's stock worth $34,232,000 after buying an additional 668,165 shares during the period. Bank of Montreal Can lifted its holdings in RELX by 290.3% in the 4th quarter. Bank of Montreal Can now owns 886,758 shares of the technology company's stock worth $40,277,000 after buying an additional 659,547 shares during the period. Finally, Carnegie Investment Counsel purchased a new stake in RELX in the 1st quarter worth approximately $16,026,000. 15.02% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have recently commented on RELX shares. Wall Street Zen upgraded RELX from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Morgan Stanley restated an "overweight" rating on shares of RELX in a research note on Wednesday, April 16th. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Buy".

RELX Stock Down 2.7%

RELX stock traded down $1.40 on Tuesday, reaching $50.57. 1,652,276 shares of the company traded hands, compared to its average volume of 1,111,325. RELX PLC has a one year low of $43.45 and a one year high of $56.33. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42. The company has a market cap of $92.88 billion, a P/E ratio of 27.19, a price-to-earnings-growth ratio of 3.39 and a beta of 0.88. The firm has a fifty day simple moving average of $53.24 and a 200-day simple moving average of $51.62.

RELX Cuts Dividend

The firm also recently announced a semi-annual dividend, which will be paid on Tuesday, September 16th. Shareholders of record on Friday, August 8th will be issued a $0.2634 dividend. The ex-dividend date of this dividend is Friday, August 8th. This represents a dividend yield of 170.0%. RELX's dividend payout ratio (DPR) is presently 65.05%.

RELX Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.